1. Donma O, Yorulmaz
E, Pekel H, Suyugul N. Blood and lens lipid peroxidation and antiox-
idant status in normal individuals, senile and diabetic cataractous
patients. Curr Eye Res. 2002 Jan;25(1):9-16.
2. Taylor A, Jacques PF, Chylack LT Jr, et al. Long-term intake
of vitamins and carotenoids and odds of early age-related cortical
and posterior subcapsular lens opac- ities. Am J Clin Nutr. 2002
Mar;75(3):540-549.
3. Valero MP, Fletcher AE, De Stavola BL, Vioque J, Alepuz VC. Vitamin
C is associat- ed with reduced risk of cataract in a Mediterranean
population. J Nutr. 2002 Jun;132(6):1299-306.
4. McNeill JJ, Robman L, Tikellis G, Sinclair MI, McCarty CA, Taylor
HR. Vitamin E sup- plementation and cataract: randomized con- trolled
trial. Ophthamology. 2004 Jan;111(1):75-84.
5. Yuneva MO, Bulygina ER, Gallant SC, et al. Effect of carnosine
on age-induced changes in senescence-accelerated mice. J Anti-Aging
Med. 1999;2:337-42.
6. Wang AM, Ma C, Xie H, Shen F. Use of carnosine as a natural anti-senescence
drug for human beings. Biochemistry. 2000 Jul;65(7);869-71.
7. Babizhayev MA, Deyev AI, Yermakova VN, et al. N-acetylcarnosine,
a natural histidine- containing dipeptide, as a potent ophthalmic
drug in treatment of human cataracts. Peptides. 2001 Jun;22(6):979-94.
8. Fong DS, Aiello L, Gardner TW, et al. Diabetic retinopathy. Diabetes
Care. 2003 Jan;26(1):226-9.
9. Kaneto H, Kajimoto Y, Miyagawa J, et al. Beneficial effects of
antioxidants in diabetes: possible protection of pancreatic beta-cells
against glucose toxicity. Diabetes. 1999 Dec;48(12):2398-406.
10. Song Y, Manson JE, Buring JE, Liu S. Dietary magnesium intake
in relation to plasma insulin levels and risk of type 2 dia- betes
in women. Diabetes Care. 2004 Jan;27(1):59-65.
11. Lopez-Ridaura R, Willett WC, Rimm EB, et al. Magnesium intake
and risk of type 2 dia- betes in men and women. Diabetes Care. 2004
Jan;27(1):134-40.
12. Anderson RA, Roussel AM, Zouari N, Mahjoub S, Matheau JM, Kerkeni
A. Potential antioxidant effects of zinc and chromium supplementation
in people with type 2 diabetes mellitus. J Am Coll Nutr. 2001 Jun;20(3):212-8.
13. Talpur N, Echard BW, Yasmin T, Bagchi D, Preuss HG. Effects
of niacin-bound chromi- um, Maitake mushroom fraction SX and (-)-
hydroxycitric acid on the metabolic syn- drome in aged diabetic Zucker
fatty rats. Mol Cell Biochem. 2003 Oct;252(1-2):369-77.
14. McCarty MF. High-dose biotin, an inducer of glucokinase expression
may synergize with chromium picolinate to enable a definitive nutritional
therapy for type II diabetes. Med Hypotheses. 1999 May;52(5):401-6.
15. Anderson RA. Nutritional factors influenc- ing the glucose/insulin
system: chromium. J Am Coll Nutr.1997 Oct;16(5):404-10.
16. Rudich A, Tirosh A, Potashnik R, Khamaisi M, Bashan N. Lipoic
acid protects against oxidative stress induced impairment in insulin
stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes.
Diabetologia. 1999 Aug;42(8):949-57.
17. Barbagallo M, Dominguez LJ, Tagliamonte MR, Resnick LM, Paolisso
G. Effects of vita- min E and glutathione on glucose metabolism: role
of magnesium. Hypertension. 1999 Oct;34(4 Pt 2):1002-6.
18. Anuradha CV, Balakrishnan SD. Taurine attenuates hypertension
and improves insulin sensitivity in the fructose-fed rat, an animal
model of insulin resistance. Can J Physiol Pharmacol. 1999 Oct;77(10):749-54.
19. Cunningham JJ. The glucose/insulin system and vitamin C: implications
in insulin- dependent diabetes mellitus. J Am Coll Nutr. 1998 Apr;17(4):105-8.
20. Han DH, Hansen PA, Chen MM, Holloszy JO. DHEA treatment reduces
fat accumula- tion and protects against insulin resistance in male
rats. J Gerontol A Biol Sci Med Sci. 1998 Jan;53(1):B19-24.
21. Shanmugasundaram ER, Rajeswari G, Baskaran K, et al. Use of
Gymnema sylvestre leaf extract in the control of blood glucose in
insulin-dependent diabetes mellitus. J Ethnopharmacol. 1990 Oct;30(3):281-94.
22. Christensen RL, Shade DL, Graves CB, McDonald JM. Evidence that
protein kinase C is involved in regulating glucose transport in the
adipocyte. Int J Biochem. 1987;19(3):259-65.
23. Romero-Navarro G, Cabrera-Valladares G, German MS, et al. Biotin
regulation of pan- creatic glucokinase and insulin in primary cultured
rat islets and in biotin-deficient rats. Endocrinology. 1999 Oct;140(10):4595-400.
24. Sarkar S, Pranava M, Marita R. Demonstration of the hypoglycemic
action of Momardica charantia in a validated ani- mal model of diabetes.
Pharmacol Res. 1996 Jan;33(1):1-4.
25. Teachey MK, Taylor ZC, Maier T, et al. Interactions of conjugated
linoleic acid and lipoic acid on insulin action in the obese Zucker
rat. Metabolism. 2003 Sep;52(9):1167-74.
26. Battell ML, Delgatty HL, McNeill JH. Sodium selenate corrects
glucose tolerance and heart function in STZ diabetic rats. Mol Cell
Biochem. 1998 Feb;179(1-2):27-34.
27. Nair AR, Biju MP, Paulose CS. Effect of pyridoxine and insulin
administration on brain glutamate dehydrogenase activity and blood
glucose control in streptozotocin- induced diabetic rats. Biochim
Biophys Acta. 1998 Aug 24;1381(3):351-4.
28. Poucheret P, Verma S, Grynpas MD, McNeill JH. Vanadium and diabetes.
Mol Cell Biochem. 1998 Nov;188(1-2):73-80.
29. Cam MC, Rodrigues B, McNeill JH. Distinct glucose lowering and
beta cell protective effects of vanadium and food restriction in streptozotocin-diabetes.
Eur J Endocrinol. 1999 Nov;141(5):546-54.
30. Bluher M, Kahn BB, Kahn CR. Extended longevity in mice lacking
the insulin receptor in adipose tissue. Science. 2003 Jan 24;299(5606):572-4.
31. Ho E, Chen G, Bray TM. Supplementation of N-acetylcysteine inhibits
NFkappaB acti- vation and protects against alloxan-induced diabetes
in CD-1 mice. FASEB J. 1999 Oct;13(13):1845-54.
32. Giuffrida S, Bucolo C, Drago F. Topical application of a nitric
oxide synthase inhibitor reduces intraocular pressure in rab- bits
with experimental glaucoma. J Ocul Pharmacol Ther. 2003 Dec;19(6):527-34.
33. Caprioli J, Sears M. Forskolin lowers intraocular pressure in
rabbits, monkeys, and man. Lancet. 1983 Apr 30;1(8331):958-60.
34. Baslow MH. Function of the N-acetyl-L-his- tidine system in
the vertebrate eye. Evidence in support of a role as a molecular water
pump. J Mol Neurosci. 1998 Jun;10(3):193-208.
35. Crabb JW, Miyagi M, Gu X, et al. Drusen proteome analysis: an
approach to the etiol- ogy of age-related macular degeneration. Proc
Natl Acad Sci USA. 2002 Nov 12;99(23):14682-7.
36. McGwin G Jr, Owsley C, Curcio CA, Crain RJ. The association
between statin use and age related maculopathy. Br J Ophthalmol. 2003
Sep;87(9):1121-5.
37. Moeller SM, Jacques PF, Blumberg JB. The potential role of dietary
xanthophylls in cataract and age-related macular degenera- tion. J
Am Coll Nutr. 2000 Oct;19(5 Suppl):522S-527S.
38. Jacques PF. The potential preventive effects of vitamins for
cataract and age-related mac- ular degeneration. Int J Vitam Nutr
Res. 1999 May;69(3):198-205.
39. McBee WL, Lindblad AS, Ferris FL III. Who should receive oral
supplement treat- ment for age-related macular degeneration? Curr
Opin Ophthalmol. 2003 Jun;14(3):159-62.
40. Bone RA, Landrum JT, Guerra LH, Ruiz CA. Lutein and zeaxanthin
dietary supple- ments raise macular pigments of these carotenoids
in humans. J Nutr. 2003 Apr;133(4):992-8.
41. Bartlett H, Eperjesi F. Age-related macular degeneration and
nutritional supplementa- tion: a review of randomized controlled tri-
als. Ophthalmic Physiol Opt. 2003 Sep;23(5):383-99.
42. Mozaffarieh M, Sacu S, Wedrich A. The role of the carotenoids,
lutein, and zeaxanthin, in protecting against age-related macular
degeneration: a review based on controver- sial evidence. Nutr J.
2003 Dec 11;2(1):20.
43. Semba RD, Dagnelie G. Are lutein and zea- xanthin conditionally
essential nutrients for eye health? Med Hypotheses. 2003 Oct;61(4):465-72.
44. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids,
vitamins A, C, and E, and advanced age-related macular degenera- tion.
JAMA. 1994 Nov 9;272(18):1413-20.
45. Smith PF, Maclennan K, Darlington CL. The neuroprotective properties
of the ginkgo biloba leaf: a review of the possible relation- ship
to platelet-activating factor (PAF). J Ethnopharmacol. 1996 Mar;50(3):131-9.
46. Seddon JM, Cote J, Rosner B. Progression of age-related macular
degeneration: associa- tion with dietary fat, transunsaturated fat,
nuts, and fish intake. Arch Ophthalmol. 2003 Dec;121(12):1728-37.
47. Cluzel C, Bastide P, Wegman R, et al. Enzymatic activities of
the retina and antho- cyanoside extracts of Vaccinium myrtillus lactate
dehydrogenase, alpha-hydroxybu- tyrate dehydrogenase, 6-phosphogluconate
dehydrogenase, glucose-6-phosphate dehy- drogenase, alpha-glycerophosphate
dehy-drogenase, 5-nucleotidase, phosphoglucose isomerase. Biochem
Pharmacol. 1970 Jul;19(7):2295-302. |